Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes. - Herman,GA.; Bergman,A.; Stevens,C.; Kotey,P.; Yi,B.; Zhao,P.; Dietrich,B.; Golor,G.; Schrodter,A.; Keymeulen,B.; Lasseter,KC.; Kipnes,MS.; et al. (J Clin Endocrinol Metab, 2006)